Chapters

Transcript

Video

Based on the CAHtalyst pediatric trial, what subgroups of children and adults with classical CAH represent ideal patients for treatment with CRF1-targeting inhibitors such as crinecerfont?

Based on the CAHtalyst pediatric trial, what subgroups of children and adults with classical CAH represent ideal patients for treatment with CRF1-targeting inhibitors such as crinecerfont?


Created by

CMEducation Resources | iQ&A Congenital Adrenal Hyperplasia (CAH) Medical Intelligence Zone 

Presenter

Phyllis W. Speiser, MD

Phyllis W. Speiser, MD

Associate Professor, Institute of Molecular Medicine
Feinstein Institutes for Medical Research
Emerita Professor, Pediatrics Donald and Barbara Zucker School of Medicine
Hofstra/Northwell
New Hyde Park, NY